The Division of Pediatric Infectious Diseases does extensive basic science and clinical research focusing on infections in the immune-compromised host, which is an understudied area in pediatrics. Many of our research efforts are a direct response to the NIH's mission of generating basic science data that can be developed into translational studies to bring new findings from the "bench to the bedside" and thereby improve patient care and outcomes.
Improving Prevention, Diagnosis and Treatment
Understanding immune response interactions with pathogens at a cellular and molecular level is essential to finding new, better and safer methods to prevent, diagnose, and treat infectious diseases in children.
With significant federal funding our current studies include:
Improving the effectiveness of vaccines and drug therapies by, developing antibody based treatments, and new low toxicity antifungal drugs, and by studying immune response interactions with pathogens at a cellular and molecular level
Studying infections caused by fungi and viruses such as, Respiratory Syncytial Virus (RSV), Pneumocystis carinii, Candida albicans, and Cryptococcus neoformans
Training the next generation of scientists seeking to prevent, diagnose and treat infectious diseases in the pediatric population.
We actively seek collaboration with other investigators doing studies in the Department of Pediatrics, in the University, in the USA and internationally.